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Objective: Adipose tissue is an endocrine tissue releasing adipokines suggested to be involved in the
pathogenesis of osteoarthritis (OA). Nevertheless, their relative contribution and exact mechanisms are
still ambiguous. The aim of this study is to compare serum adipokine levels between end-stage knee OA
patients and controls and to relate these serum levels to local parameters of cartilage damage and
synovial inﬂammation.
Methods: Serum was collected from 172 severe knee OA patients, shortly before total knee replacement
(TKR) surgery and from 132 controls without radiographic knee OA [Kellgren & Lawrence (K&L) ¼ 0].
Serum adiponectin, leptin, and resistin levels were measured by enzyme-linked immunosorbent assay
(ELISA). Cartilage and synovial tissue were collected at TKR surgery and assessed for cartilage degen-
eration and synovial inﬂammation by histochemistry and biochemical analyses.
Results: The adipokine levels were all distinctly higher in OA patients as compared to controls. Especially
adiponectin and leptin were associated with female gender (stand beta ¼ 0.239 and 0.467, respectively,
P < 0.001) and body mass index (BMI) (stand beta ¼ 0.189 and 0.396, respectively, P < 0.001). No
associations between serum levels of adipokines and cartilage damage (histochemistry, proteoglycan
content) were found whereas weak but positive associations with synovial inﬂammation were found
[adiponectin and interleukin-1b (IL-1b), stand beta ¼ 0.172, P ¼ 0.02; resistin and histology, stand
beta ¼ 0.183, P ¼ 0.034, adjusted for demographics].
Conclusion: This study suggests an important involvement of adipokines in OA patients considering their
high serum levels compared to controls. Associations of systemic adipokines with local synovial tissue
inﬂammation were found, although not represented by similar relations with cartilage damage,
suggesting that adipokines are of relevance in the inﬂammatory component of OA.
 2012 Osteoarthritis Research Society International. Published by Elsevier Ltd. All rights reserved.Introduction
Obesity has not only been associated with an increased risk of
osteoarthritis (OA) in weight-bearing joints such as hips and
knees1,2, but also in non-weight bearing joints such as those of the
hand2. Therefore, besides biomechanical factors mediating this
relationship between OA and obesity3,4, also metabolic factors have
been suggested to be involved2,5e10..P.J.G. Lafeber, Department of
ty Medical Center Utrecht,
lands. Tel: 31-088-755-8521;
afeber).
s Research Society International. PWhite adipose tissue is considered to be a metabolically active
endocrine organ that secretes inﬂammatory cytokines [e.g., inter-
leukin-1b (IL-1b) and tumour necrosis factor-a (TNFa)] and adi-
pokines, such as adiponectin, leptin, and resistin6. Besides their
established role in obesity, metabolic disorders, and atheroscle-
rosis, the potential role of adipokines in OA pathogenesis is at
present an important subject of study10e12. Based on these studies,
OA has been designated by some authors as a metabolic syndrome
disorder13. However, the exact role and relevance of adipokines in
OA are still unclear12.
Adiponectin is a protein secreted by adipocytes and plays a role
in glucose and lipid homeostasis14. Circulating levels of adiponectin
are low in obese individuals and increase with weight loss15. The
role of adiponectin in OA is controversial: there is conﬂictingublished by Elsevier Ltd. All rights reserved.
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aggravating role in OA. For example, decreased adiponectin levels
in both plasma and synovial ﬂuid have been associated with
increased OA severity indicating that it may play a protective role in
OA16. Likewise, adiponectin has been shown to up-regulate tissue
inhibitor of metalloproteinase (TIMP)-2 and down-regulate IL-1b-
induced matrix metalloproteinase (MMP)-13 messenger RNA
(mRNA) and protein levels17. Accordingly, higher levels of adipo-
nectin have been associated with lower Kellgren & Lawrence (K&L)
grades in knee OA16 and a lower risk for progression in hand OA18.
In contrast, also proinﬂammatory tissue destructive effects of adi-
ponectin have been demonstrated on chondrocytes and synovial
ﬁbroblasts, inducing key mediators of cartilage degeneration such
as nitric oxide (NO), IL-6, IL-8, monocyte chemo-attractant protein
(MCP)-1, MMP-3 and MMP-919e21. Moreover, it has been demon-
strated that serum levels of adiponectin were increased in erosive
OA as compared to non-erosive OA22.
Leptin is a protein thought to play a key role in the regulation of
body weight by suppressing food intake and stimulating energy
expenditure by acting on the hypothalamus23,24. Mice with
a mutation in the gene for leptin (ob/obmice) or the leptin receptor
(db/db mice) have an obese phenotype25. Osteophytes, synovium,
cartilage, inﬂammatory cells, and the infrapatellar fat pad can
secrete leptin26e28. Leptin is also produced by immune cells upon
stimulationwith IL-1, IL-6 and lipopolysaccharide (LPS)28. Evidence
is increasing that leptin has a proinﬂammatory role in the patho-
physiology of OA12. Higher leptin levels produced by human oste-
oarthritic cartilage as compared to normal cartilage have been
observed26,29,30. Proteolytic enzymes like MMPs and cysteine
proteases at both gene and protein level are increased by leptin12.
Leptin appears to be involved in the pathological changes of all
tissues involved in the process of OA12. Nevertheless, it is still
unclear what the exact mechanism of leptin in the development of
OA is as leptin may act dually, inducing both catabolic26,31 and
anabolic8 effects on articular cartilage.
Resistin is a dimeric protein produced by adipocytes and
macrophages and induces insulin resistance in mice28,32. Levels are
(partly) dependent on leptin activity as in leptin activity deﬁcient
mouse models (ob/ob and db/db) serum resistin levels are raised32.
In humans, resistin appears to have a more important role in
inﬂammatory processes than it has in insulin resistance, as serum
levels of resistin correlate betterwith subclinical inﬂammation than
with insulin resistance33. Expression of resistin mRNA in human
peripheral blood mononuclear cells (PBMCs) is increased by the
proinﬂammatory cytokines IL-1, IL-6 and TNF34. Resistin can be
detected locally in the synovium of inﬂamed joints in both rheu-
matoid arthritis (RA) and OA27,33,35. Nevertheless, the exact role ofTable I
Characteristics of subjects
OA (n ¼ 172)
Age (years) 67.4 (8.4)* [49.7e
Women/Men 119/53
BMI (kg/m2) 29.5 (5.3)* [19.4e
K&L 3.1 (0.7)* [1e4]
WOMAC pain 55.7 (18.9) [5.0e1
WOMAC stiffness 62.6 (23.2) [0.0e1
WOMAC function 73.8 (20.3) [0.0e1
Adiponectin (mg/ml) 21.21 (12.94)* [5.08e
Leptin (mg/ml) 0.073 (0.061) * [0.003
Resistin (mg/ml) 0.025 (0.089)* [0.002
Data shown are means (SD) [range].
WOMAC values are on a scale from 0 to 100, 0 meaning no pain, joint stiffness and limita
function.
Signiﬁcant differences of OA subjects compared to controls are indicated by an asterisk.resistin in OA is unknown. Two studies showed no association
between serum resistin levels and progression of hand OA18,22.
The role of adipokines in OA has thus far been investigated in
mice models, in in vitro studies using human joint tissues and
ﬂuids, or systemic levels have been described in relation to joint
characteristics by use of indirect markers such as radiographic joint
damage. A relation between systemic serum adipokines and actual
local joint tissue changes in OA has never been investigated. In the
present study, along with serum concentrations of adiponectin,
leptin, and resistin, parameters of synovial tissue inﬂammation and
cartilage degeneration were measured in patients with end-stage
knee OA undergoing total knee replacement (TKR) surgery. It was
anticipated that systemic adipokine levels would be related to
synovial inﬂammation and with that to cartilage damage.
Material and methods
Patient characteristics
Patients at the Sint Franciscus Gasthuis in Rotterdam, The
Netherlands, with severe knee OA who were eligible for TKR
surgery, were included. At time of TKR surgery, blood, cartilage
tissue, and synovial tissue were collected36. Cartilage and synovial
tissue were kept in phosphate buffered saline for a maximum of 4 h
during transport to the University Medical Centre Utrecht where
tissues were further processed under laminar ﬂow conditions.
Controls, fromwhom blood was collected, had recent complaints of
pain and/or stiffness of the knee and/or hip related to very early OA,
but had no signs of radiological OA as deﬁned by a K&L score of 0 on
radiographs of both knees and both hips. These controls were
matched for sex.
Demographic characteristics and Western Ontario and McMas-
ter Universities Arthritis Index (WOMAC) scores of the OA patients
and controls are shown in Table I. The study was conducted
according to the declaration of Helsinki and received approval from
the ethics committee of the hospital. Written informed consent was
obtained from all patients before inclusion.
Serum adipokines in OA and controls
From both cohorts, blood samples were centrifuged, serum was
separated, and aliquots stored at 80C. Serum concentrations of
adiponectin, leptin, and resistin were measured by enzyme-linked
immunosorbent assay (ELISA) (BioVendor, Modrice, Czech
Republic). Samples were prepared at appropriate dilutions and all
samples were assessed according to the manufacturer’s instruc-
tions. Internal control samples were used as supplied by theControls (n ¼ 132)
89.1] 56.5 (4.5) [50.0e66.0]
98/34
46.8] 28.1 (3.8) [19.9e48.8]
0.0 (0.0) [0e0]
00.0] 22.7 (16.0) [0.0e60.0]
00.0] 29.5 (19.4) [0.0e75.0]
00.0] 21.6 (17.4) [0.0e73.5]
66.06] 11.29 (5.51) [2.81e31.74]
e0.293] 0.018 (0.013) [0.001e0.056]
e0.053] 0.004 (0.001) [0.001e0.010]
tions in function, and 100 meaning maximum pain, joint stiffness and limitations in
T.N. de Boer et al. / Osteoarthritis and Cartilage 20 (2012) 846e853848manufacturer. Quality controls demonstrated adequate measure-
ments for all patients for all three adipokines. Intra- and inter-plate
coefﬁcients of variation [CV%, standard deviation (SD)/mean*100%]
as determined from triplicate assessment of a single standard
sample in each assay plate were as follows: adiponectin: intra-
assay CV ¼ 11.41%, inter-assay CV ¼ 18.44%; leptin: intra-assay
CV ¼ 5.0%, inter-assay CV ¼ 37.3%; resistin: intra-assay
CV ¼ 17.0%, inter-assay CV ¼ 5.9%.Parameters of cartilage damage in OA patients
For histochemistry, four cartilage tissue samples (range
5e10 mg, accuracy 0.1 mg) were taken randomly from the cartilage
still present on the joint. These samples were ﬁxed in 4% phosphate
buffered formalin with 2% sucrose. After embedding in parafﬁn
wax, 5 mm sections were sliced and stained with Safranin-O fast
green-iron haematoxylin according to standard procedures37.
Cartilage damage was scored using the modiﬁed Mankin score38,39.
For biochemistry, 20 randomly taken cartilage samples of each
donor were used for biochemical analysis of glycosaminoglycan
(GAG) content as a measure of proteoglycan content according to
standard procedures40. In short, after digestion of the cartilage
samples with papain, GAGs were precipitated and stained with
Alcian Blue. Blue stainingwas quantiﬁed photometrically by change
in absorbance at 620 nm. Chondroitin sulphate (C4383; Sigma) was
used as reference. Values for proteoglycan content were normal-
ized to the wet weight of the cartilage sample and expressed as
milligrams of GAG per gram wet weight of cartilage tissue (mg/g).Parameters of OA synovial tissue inﬂammation
For histochemistry, three synovial tissue samples (range
50e150 mg, accuracy 0.1 mg) obtained at TKR surgery from the
suprapatellar region of the knee joint were ﬁxed and embedded
and sections stained with haematoxylin-eosin. Synovial tissue
inﬂammation was graded using the modiﬁed Goldenberg and
Cohen score41,42. In brief, the severity of synovitis was graded from
0 to 10 by adding the scores of three histological criteria, namely
synovial lining cell hyperplasia (0e2), villous hyperplasia (0e3),
and cellular inﬁltration by (perivascular) mononuclear and poly-
morphonuclear leukocytes (0e5). For assessing the overall grade
the three specimens of each knee were considered as a unit.
To measure ex vivo proinﬂammatory cytokine production IL-1b
and TNFa production by the OA synovial tissue were determined.
Synovial tissue samples obtained from the suprapatellar region of
the knee joint eachweighing 50e150mgwere cultured individually
for 3 days in 4 ml culture medium (Dulbecco's modiﬁed eagle
medium (DMEM) supplemented with 2 mM glutamine, 100 IU/ml
penicillin,100 mg/ml streptomycin sulphate, 0.085mMascorbic acid
and 10% heat inactivated pooled humanABþ serum at 37C, 5% CO2).
In the culture supernatants IL-1b and TNFa were determined byTable II
Relationship between serum adipokines and the state of disease, adjusted for demograp
Adiponectin* Leptin*
Linear regression coefﬁcient
Standardized b
P Linear regre
Standardize
State (OA) 0.378 <0.001 0.539
Age (years) 0.224 <0.001 0.045
Gender (female) 0.239 <0.001 0.467
BMI (kg/m2) L0.189 <0.001 0.396
Bold values represent P < 0.05 that were considered statistically signiﬁcant.
* Logarithmic transformation was performed to obtain normal distribution.ELISA (Biosource) according to manufacturer’s instructions and
expressed as pg/ml per mg synovial tissue.
Statistical analysis
For histochemistry, two observers blinded to the source of the
samples scored all samples and the average scores of observers
were taken as representative score of each sample. In a few cases
consensus was sought when observers scored >1 point difference.
The average of all multiple tissue samples (n ¼ 4 for cartilage
histology, n¼ 20 for cartilage GAG content, n¼ 3 for synovial tissue
histology, and n ¼ 3 for cytokine production) of each donor was
taken as representative value for each donor. Data are subsequently
expressed as the mean (SD) of donors with n representing the
number of donors, unless stated otherwise. Continuous variables
were evaluated using Student’s t tests, ordinal variables by Chi-
square tests. Linear regression analysis was used to compare adi-
pokine levels between patients and controls, and to study the effect
of local joint characteristics on serum adipokine levels. Skewed
variables (IL-1b, TNFa, and adipokines) were logarithmically
transformed so that normal distribution was obtained. To facilitate
direct comparison between regression coefﬁcients of variables and
models, coefﬁcients are expressed as standardized betas. Stan-
dardized betas represent the number of SDs that the outcome will
change as a result of one SD change in the predictor and are
therefore independent of the units of measurement of the variables
and can vary between 1 and 1. Unadjusted standardized betas are
identical to Pearson’s correlation coefﬁcients. In all analyses
P < 0.05 was considered statistically signiﬁcant. All statistical
analyses were performed using Statistical package for the social
sciences (SPSS) (standard version 15.0, SPSS, Chicago, IL, USA).
Results
Patient characteristics
The characteristics of the 172 OA patients and the 132 controls
are shown in Table I. Controls were younger than OA patients
(P < 0.001). In addition, the BMI was statistically signiﬁcantly
higher in OA patients than in controls (P < 0.001). By selection, the
radiological joint damage (P < 0.001) was higher in the OA patients
and gender distribution was similar for both groups. All serum
adipokine levels were evidently higher in the OA population
compared to the control population, independent of age and BMI
differences (Table II).
The joints of the OA patients showed on average the typical
characteristics of severe OA. Besides the radiological joint damage,
also cartilage histology demonstrated moderate damage with
a modiﬁed Mankin score of 4.7 1.0 (range 0e11), typical of such an
end-stageOApopulation40. Thiswasalso reﬂected in theGAGcontent
of the cartilage (24.4 5.6 mg/g wet weight), clearly lower than that
of healthy cartilage39. Additionally, a mild inﬂammatory synovialhic variables
Resistin*
ssion coefﬁcient
d b
P Linear regression coefﬁcient
Standardized b
P
<0.001 0.977 <0.001
0.198 L0.062 0.014
<0.001 0.002 0.914
<0.001 0.031 0.131
T.N. de Boer et al. / Osteoarthritis and Cartilage 20 (2012) 846e853 849activity was observed. The synovial tissue was graded as moderately
inﬂamed with a modiﬁed Goldenberg and Cohen score of 5.0  1.2
(range0e10), and IL-1b andTNFaproductionof 11.723.2pg/ml and
2.3  3.0 pg/ml per mg synovial tissue, respectively.
Relationship between the different adipokine levels and BMI, gender,
and age in end-stage knee OA patients
Adiponectin showed a negative correlation with BMI
(R ¼ 0.222, P ¼ 0.004), leptin a positive correlation (R ¼ 0.599,
P< 0.001), and resistin demonstrated no clear BMI dependency. On
average, all serum adipokine levels were higher in women than in
men (P < 0.001 for adiponectin and leptin and no statistical
signiﬁcance, P ¼ 0.161, for resistin) [See Fig. 1(A)]. Adiponectin
showed an evidently positive correlation with age (R ¼ 0.276,
P < 0.001), leptin levels showed no relation with age, and resistin
showed a minor negative relationwith age (R¼0.222, P¼ 0.007).
The control population showed comparable relations with BMI,
gender, and age [see Fig. 1(B)] but clearly less profound, probably
due to the limited variation in adipokine levels (limitedwindow; see
Table I). For leptin, the positive correlationwith BMIwas statistically
signiﬁcant (R ¼ 0.555, P < 0.001) and the higher levels in women
compared to men was statistically signiﬁcant (P < 0.001). Resistin
showedborderline signiﬁcantly higher levels inwomen than inmen
(P ¼ 0.072). All other relations were not statistically signiﬁcant.
Relationship between serum adipokines and local parameters of
cartilage tissue degeneration
Unexpectedly, linear regression analysis showed no association
between any parameter of cartilage degeneration and serum adi-
pokine levels. Separate analysis of men and women as well as
adjustment for age, gender and BMI did also not demonstrate any
statistically signiﬁcant association (all P > 0.1, data not shown).
Relationship between serum adipokines and local parameters of
synovial tissue inﬂammation
In contrast with the aforementioned absence of associations
between adipokines and cartilage damage, local synovial tissue
inﬂammation was (marginally) related to serum adipokine levels
(Table III). Resistin levels were statistically signiﬁcantly positively
associated with histologically determined grade of synovial tissue
inﬂammation (P ¼ 0.026, R2 ¼ 0.038).
After adjustment for age, gender, and BMI, an association
between IL-1b production and adiponectin became apparent (P ¼
0.020, R2 ¼ 0.285). Resistin levels remained statistically signiﬁ-
cantly associated with histological grade of synovial tissue
inﬂammation (P ¼ 0.034, R2 ¼ 0.101).
Discussion
Clearly higher serum levels of all three adipokines in end-stage
knee OA patients were found compared to controls without any
radiographic sign of cartilage damage, independent of BMI, age, and
gender. In the OA population clear relations with age were found
for adiponectin and resistin and with BMI for adiponectin and
leptin. No associations were found between serum adipokine levels
and cartilage damage whereas a marginally positive association
with synovial inﬂammation was found.
Large studies on multiple simultaneously assessed serum adi-
pokine levels in knee OA patients as compared to controls are
scarce. Most studies are only small, focus on single adipokines, and/
or focus on hand OA or cardiovascular/metabolic disease. Therefore
our study provides new data on many aspects of serum adipokinelevels and demographics in knee OA patients. Potential differences
between female and male knee OA patients for serum adipokine
levels have not been described thus far, except for one study in 30
knee OA patients demonstrating statistically signiﬁcantly different
plasma leptin levels between female and male patients in univar-
iate correlation analysis, without specifying which gender showed
the highest levels, while adiponectin levels were similar between
both genders43. Our study demonstrates higher adiponectin and
leptin levels in female compared to male knee OA patients, not
attributable to differences in BMI and age. Also in healthy subjects,
adiponectin and leptin levels have been reported to be higher in
women than in men. These differences could not be completely
explained by antropomorphometric differences of body fat distri-
bution between genders44e48.
The inﬂuence of BMI on serum adipokine levels observed in our
end-stage OA cohort is conform literature, adiponectin negatively
correlating with BMI47,49,50, and leptin positively correlating with
BMI30 in healthy subjects. Apparently, these relations persist in
end-stage knee OA. Most studies show either no or a positive
correlation between resistin and BMI in various patient catego-
ries51e53. To the best of our knowledge, this has never been
demonstrated in knee OA subjects as ours, which shows no corre-
lation between resistin and BMI.
Our study with exclusively end-stage OA patients demonstrates
evidently increased serum adipokine levels in knee OA patients
compared to controls. A small study by Honsawek et al. showed
increased plasma adiponectin levels in K&L grade 2 OA subjects
compared to controls, but decreased levels in K&L grade 4 OA
subjects16,54. Choe et al. showed increased serum resistin levels in
radiographic hand OA patients compared to non-radiographic hand
OA patients and controls55. To the best of our knowledge, our study
is the ﬁrst one that demonstrates increased serum leptin and
resistin levels in knee OA patients compared to controls.
The control subjects in our study had pain and/or stiffness of
knee(s) and/or hip(s), but did not have grossly visible radiographic
knee OA (i.e., K&L grade 0)56,57. Nevertheless, more subtle individual
radiographic OA features as determined by Knee Image Digital
Analysis could be observed in these subjects58. Irrespective, using
these subjects as (disease) controls might have led to underesti-
mation, but never overestimation, of the difference between adi-
pokine levels of end-stage knee OA patients and controls.
Direct comparison between the patient and control population
was hampered by differences in age and BMI between them, since
age and BMI were associated with serum adipokine levels.
However, the observed differences persisted after adjustment for
these differences in multiple linear regression analysis.
This study is the ﬁrst to relate serum adipokine levels directly to
local synovial tissue inﬂammation of the OA joint albeit marginally.
Although the three adipokines generally showed positive correla-
tions with synovial inﬂammation, relations were not very robust.
Adiponectin showed a statistically signiﬁcant positive correlation
with synovial IL-1b production, thereby suggesting a relation with
proinﬂammatory features in OA. Resistin was also positively asso-
ciated with parameters of synovial inﬂammation. Accordingly,
resistin levels have been shown to be elevated in RA patients and
show a correlation with inﬂammation and joint destruction in
RA33,59. It has been stated that the infrapatellar fat pad shows an
inﬂammatory phenotype with its cytokine and adipokine produc-
tion, and therefore contributes to the pathophysiological changes in
OA60. In general it is to be considered that systemic (serum) and
local adipokine levels are involved in local synovial tissue inﬂam-
mation in OA although relations are not strong.
Based on available literature on the involvement of adipokines in
OA pathogenesis, it was anticipated that (part of the) adipokines
would (also) relate to cartilage damage in the OA joints. However, in
Fig. 1. Relationship between serum adipokine levels and BMI, gender and age in end-stage OA patients (A) and controls (B). Statistics are as obtained from Pearson’s correlation
analysis.
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Table III
Relationship between serum adipokines and local inﬂammation parameters in end-stage knee OA patients
Linear regression
Standardized b
P R2 Multiple linear regression
Standardized b*
P R2
Adiponectiny
Histology 0.027 0.754 0.001 0.049 0.514 0.293
IL-1by 0.101 0.230 0.016 0.172 0.020 0.285
TNFay 0.054 0.521 0.003 0.084 0.268 0.254
Leptiny
Histology 0.015 0.862 0.000 0.076 0.142 0.676
IL-1by 0.078 0.363 0.006 0.002 0.971 0.692
TNFay 0.106 0.219 0.011 0.012 0.802 0.694
Resistiny
Histology 0.194 0.026 0.038 0.183 0.034 0.101
IL-1by 0.114 0.202 0.013 0.128 0.152 0.079
TNFay 0.083 0.360 0.007 0.140 0.118 0.087
Bold values represents P < 0.05 that was considered statistically signiﬁcant.
* Adjusted for age, gender, and BMI.
y Logarithmic transformation was performed to obtain normal distribution.
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histology and proteoglycan levels of the cartilage, was observed. This
apparently contrasts with ﬁndings of others. For example, leptin
levels were shown to be positively correlated with hip joint space
narrowing grade in randomly selected subjects aged 52e78 years44.
Pathogenetic differences between knee and hip OA as well as differ-
ences in OA severity, end-stage compared to mild to moderate
disease, might be explanatory for the discrepancywith our results. In
knee OA patients, plasma and synovial ﬂuid adiponectin levels
showednegative correlationswithkneeOAK&L grade16. This relation
onlypersisted for synovialﬂuid levels afteradjusting fordemographic
variables. The latter ﬁts the absence of a correlation between serum
adipokine levels and actual cartilage damage in the present study.
Amajor difference between all previously performed studies and
our study is that most of them quantify cartilage damage radio-
graphically, whilewe quantiﬁed cartilage damage histologically and
biochemically. Although the evaluation of the cartilage itself instead
of surrogate markers is more direct, it might also be more sensitive
to the noise that results from all complex dynamics that continu-
ously take place within the joint. On the other hand, recent obser-
vations suggested a clear relation between actual cartilage damage
and features of radiographic joint damage including K&L grading.
Furthermore, our local cartilage parameters might be biased
because evaluation of articular cartilage did not take into account
denuded bone areas. Reassuring in this respect is that also macro-
scopic cartilage scores including denuded bone areas did not show
statistically signiﬁcant associationswith any of the adipokines (data
not shown). It should be emphasized that serum levels of adipo-
kines will be associated not only with OA in the knee, but also with
OA in other joints. Data on these joints are not available as such
these joints could not be included in the current study.
In conclusion this study supports involvement of adipokines in
knee OA. Serum adipokine concentrations were evidently increased
in knee OA patients as compared to controls, independent of age
and BMI. Some relations between systemic adipokines and local
synovial tissue inﬂammation were found although not represented
by similar relations with actual cartilage damage, implying adipo-
kines are especially of relevance in the inﬂammatory component of
the disease, and cartilage degeneration to be dominated by other,
presumably intrinsic, processes.Author contributions
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